“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

For newborns and infants, whose immune systems are still developing, and airways are small, RSV can quickly become serious.

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory ...

RSV vaccines will be most effective at saving lives if given before infections climb, which happened unusually early last year. "Lives, hospitalizations, we could have a significant impact this year.

Supply of RSV antibody shot struggling to meet demand Atlanta — Lucas Cerna's mother is getting him a respiratory syncytial virus shot while his pediatrician still has it in stock.

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

The primary cohort (to assess the RSV outcome) was comprised of 18,767 children with SARS-CoV-2 infection, 6,697 with ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...